ATE546520T1 - Faktor-xi-reinigung - Google Patents

Faktor-xi-reinigung

Info

Publication number
ATE546520T1
ATE546520T1 AT08701217T AT08701217T ATE546520T1 AT E546520 T1 ATE546520 T1 AT E546520T1 AT 08701217 T AT08701217 T AT 08701217T AT 08701217 T AT08701217 T AT 08701217T AT E546520 T1 ATE546520 T1 AT E546520T1
Authority
AT
Austria
Prior art keywords
factor
cleaning
methods
hcic
blood coagulation
Prior art date
Application number
AT08701217T
Other languages
English (en)
Inventor
Paul Henri Markus
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Application granted granted Critical
Publication of ATE546520T1 publication Critical patent/ATE546520T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
AT08701217T 2007-01-04 2008-01-03 Faktor-xi-reinigung ATE546520T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87850907P 2007-01-04 2007-01-04
EP07100123 2007-01-04
PCT/EP2008/050035 WO2008081025A1 (en) 2007-01-04 2008-01-03 Purification of factor xi

Publications (1)

Publication Number Publication Date
ATE546520T1 true ATE546520T1 (de) 2012-03-15

Family

ID=38038498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08701217T ATE546520T1 (de) 2007-01-04 2008-01-03 Faktor-xi-reinigung

Country Status (5)

Country Link
US (1) US20100062512A1 (de)
EP (1) EP2102335B1 (de)
AT (1) ATE546520T1 (de)
DK (1) DK2102335T3 (de)
WO (1) WO2008081025A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101639454B1 (ko) * 2008-07-15 2016-07-13 크루셀 홀란드 비.브이. Ｐｅｒ．ｃ6 세포의 배양에 대한 확장가능 방법 및 그 방법으로 생산된 산물
SE1050124A1 (sv) 2010-02-08 2011-08-09 Linkoping Biocontrols Ab Stabil lösning
RU2015149979A (ru) 2010-03-30 2019-01-15 Октафарма Аг Способ очистки белка фактора роста
AU2011331208B2 (en) * 2010-11-16 2016-12-01 Octapharma Ag A process for reduction and/or removal of FXI and FXIa from solutions containing said coagulation factors
DE102012022234A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Einstufiges Verfahren zur Reinigung von (Blut)Plasmaproteinen wie Albumin aus Gemischen
DE102012022233A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Verfahren zur Reinigung eines (Blut)plasmaproteins
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676231A1 (fr) * 1991-05-07 1992-11-13 Aetsrn Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
AU749177B2 (en) * 1997-10-23 2002-06-20 Fujimori Kogyo Co. Ltd. Method for purifying thrombin substrates and/or inhibitors or method for eliminating the same
US7138262B1 (en) * 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
TWI319007B (en) * 2002-11-06 2010-01-01 Novozymes As Subtilase variants
NZ562949A (en) * 2005-04-11 2009-05-31 Medarex Inc Protein purification using HCIC and ion exchange chromatography

Also Published As

Publication number Publication date
EP2102335A1 (de) 2009-09-23
WO2008081025A1 (en) 2008-07-10
EP2102335B1 (de) 2012-02-22
US20100062512A1 (en) 2010-03-11
DK2102335T3 (da) 2012-05-07

Similar Documents

Publication Publication Date Title
LTPA2020536I1 (lt) Nauji anti-CD38 antikūnai, skirti vėžio gydymui
ATE546520T1 (de) Faktor-xi-reinigung
NL301089I2 (nl) imlifidase
LTC2567976I2 (lt) Antikūnai prieš CD38 antigeną, skirti išsėtinės mielomos gydymui
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
EA200971077A1 (ru) Гетероциклические модуляторы киназы
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
IS8516A (is) Fosfónöt, monofosfónamidöt, bisfosfónamidöt til meðhöndlunar á veirusjúkdómum
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
TW200740844A (en) Novel MAdCAM antibodies
DK3056568T3 (da) Fremgangsmåder til kontrollering af antistoffers blodfarmakokinetik
EA200802213A1 (ru) Способы лечения заболеваний крови
EA200970403A1 (ru) Бициклические триазолы в качестве модуляторов протеинкиназы
DK3401334T5 (da) Monoklonale antistoffer mod claudin-18 til cancerbehandling
EA201000903A1 (ru) Антитела к pcrv-антигену pseudomonas aeruginosa
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.
ITMO20050195A1 (it) Macchina per il trattamento extracorporeo di sangue
EA201101241A1 (ru) Лечение лейкозов и хронических миелопролиферативных болезней антителами к ерна3
DK2109623T3 (da) Cancerbehandling med anti-IL-1-antistoffer
EA201000258A1 (ru) Новые гербициды
WO2011091308A3 (en) Pipette tips
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
EA200900261A1 (ru) Применение эсцина